These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 949564)
1. Facility for small volume parenteral manufacturing. Kelly PC Bull Parenter Drug Assoc; 1976; 30(2):72-9. PubMed ID: 949564 [No Abstract] [Full Text] [Related]
5. I. Federal regulations concerning use of asbestos filters in manufacturing parenteral drugs. Casola AR Bull Parenter Drug Assoc; 1975; 29(5):216-8. PubMed ID: 1182330 [No Abstract] [Full Text] [Related]
6. [Prepartion of an infusion under laminar air flow]. Soins; 1976 Dec 5-20; 21(23-24):75-6. PubMed ID: 1050903 [No Abstract] [Full Text] [Related]
7. IV additive service. McLemore RA Hospitals; 1971 Mar; 45(6):96-8. PubMed ID: 5547690 [No Abstract] [Full Text] [Related]
8. [Evolution of manufacturing conditions and facilities in the pharmaceutical industry]. Lhoest W J Pharm Belg; 2005; 60(4):109-16. PubMed ID: 16429832 [No Abstract] [Full Text] [Related]
10. Sterility-testing program for antibiotics and other intravenous admixtures. Choy FN; Lamy PP; Burkhart VD; Tenney JH Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640 [No Abstract] [Full Text] [Related]
11. [Study of compounding changes in parenteral injections by thin-layer chromatography. 1]. Tanaka K; Sakamoto Y; Nakai T Iryo; 1968 Oct; 22(10):1109-14. PubMed ID: 4885315 [No Abstract] [Full Text] [Related]
12. Precipitates found in admixtures of potassium chloride and dextrose 5 percent in water. Kramer W; Tanja JJ; Harrison WL Am J Hosp Pharm; 1970 Jul; 27(7):548-53. PubMed ID: 5431053 [No Abstract] [Full Text] [Related]
13. [Problems with infusion mixtures in health departments]. Malý J; Samková M Zdrav Prac; 1975 Oct; 25(10):597-600. PubMed ID: 1045763 [No Abstract] [Full Text] [Related]
14. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973 [TBL] [Abstract][Full Text] [Related]
15. Parenteral incompatibilities--past, present and future. Parker EA; Boomer RJ; Bell SC Bull Parenter Drug Assoc; 1967; 21(6):197-207. PubMed ID: 6078886 [No Abstract] [Full Text] [Related]
16. Predicting pharmaceutical incompatibilities of parenteral medications. Carlin HS; Perkins AJ Am J Hosp Pharm; 1968 Jun; 25(6):270-9. PubMed ID: 5656772 [No Abstract] [Full Text] [Related]
17. A comparison of the pump syringe method with other methods for adding potassium chloride to Travenol large-volume parenterals. Moeller KA; Clyne KE Hosp Pharm; 1980 Dec; 15(12):605-7. PubMed ID: 10249421 [No Abstract] [Full Text] [Related]
18. Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions. Anschel J; Mollica JA; Lin KS Bull Parenter Drug Assoc; 1972; 26(6):271-89. PubMed ID: 4629105 [No Abstract] [Full Text] [Related]
19. A comparison of premixed and non-premixed potassium chloride large-volume parenterals. Turco SJ Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085 [No Abstract] [Full Text] [Related]
20. Cost and time required to add potassium chloride to large-volume parenterals. Turco SJ Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084 [No Abstract] [Full Text] [Related] [Next] [New Search]